Middle East & Africa Pharmaceutical Cro Market Size & Outlook
Middle East & Africa pharmaceutical cro market, 2018-2030 (US$M)
Related Markets
MEA pharmaceutical cro market highlights
- The MEA pharmaceutical cro market generated a revenue of USD 1,980.6 million in 2024.
- The market is expected to grow at a CAGR of 7.4% from 2025 to 2030.
- In terms of segment, clinical was the largest revenue generating type in 2024.
- Pre-Clinical is the most lucrative type segment registering the fastest growth during the forecast period.
- Country-wise, Kuwait is expected to register the highest CAGR from 2025 to 2030.
MEA data book summary
| Market revenue in 2024 | USD 1,980.6 million |
| Market revenue in 2030 | USD 3,045.4 million |
| Growth rate | 7.4% (CAGR from 2024 to 2030) |
| Largest segment | Clinical |
| Fastest growing segment | Pre-Clinical |
| Historical data covered | 2018 - 2023 |
| Base year for estimation | 2024 |
| Forecast period covered | 2025 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Drug Discovery, Pre-Clinical, Clinical |
Other key industry trends
- In terms of revenue, MEA region accounted for 4.8% of the global pharmaceutical cro market in 2024.
- Globally, Asia Pacific is projected to lead the regional market in terms of revenue in 2030.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 32,105.5 million by 2030.
Clinical was the largest segment with a revenue share of 75.43% in 2024. Horizon Databook has segmented the Middle East & Africa pharmaceutical cro market based on drug discovery, pre-clinical, clinical covering the revenue growth of each sub-segment from 2018 to 2030.
Middle Eastern countries such as South Africa, Saudi Arabia, the United Arab Emirates (UAE), and Kuwait are prospering economies. The pharmaceutical CRO market in the MEA region is likely to grow steadily in the coming years. The increasing healthcare expenditure, rising demand for various therapeutics, R&D investments, and technological advancements.
Several countries in the region are implementing global standards and collaborating with other global CROs to establish a presence in the market. Besides, the growing number of clinical trials is anticipated to boost market growth.
Moreover, less competition between pharmaceutical companies in underdeveloped countries of the region is attracting various pharmaceutical startups, resulting in regional market growth.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Pharmaceutical CRO Market Scope
Pharmaceutical CRO Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
MEA pharmaceutical cro market size, by country, 2018-2030 (US$M)
Middle East & Africa Pharmaceutical CRO Market Outlook Share, 2024 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
